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Surnrnary. A short history and summary of the 
occurrence of substance P in the vertebrate body is 
presented. Substance P is now generally accepted to be a 
neurotransmitter and can be visualized by immunocyto- 
chemistry to occur in various nerve cells in the CNS. In 
the retina, substance P-immunoreactivity (SP-IR) occurs 
in amacrine cell populations in al1 the species so far 
studied. In some vertebrates retinas SP is also apparent 
in one or more ganglion cell  types. Anatomical 
investigations have revealed the morphology and 
connectivity of SP-IR amacrine cells: they branch in 
severa1 strata of the inner plexiform layer receiving input 
from bipolar and amacrine cells and making synapses 
upon bipolar and ganglion cells. Most commonly SP-IR 
amacrines emit axon-like process that pass to both the 
outer plexiform layer and the ganglion cell and nerve 
fiber layers. These processes often end upon the retina1 
vasculature. 
SP-IR ganglion cells have been described in turtle, 
rabbit and human retinas. In turtle, intracellular dye 
injection has revealed the morphology of one type of SP- 
IR ganglion cell as being a large-field monostratified cell 
with a branches in the outer stratum of the inner 
plexiform layer. It may correspond to a «Dogiel cell» 
type. Intracellular investigation of SP-IR amacrine cells 
in turtle reveal their physiological responses to be ON- 
OFF in nature with some color-coding characteristics. In 
general SP acts as an excitatory neurotransmitter raising 
the spontaneous activity leve1 of ganglion cell responses. 
The SP-IR ganglion cell is an OFF-center unit in the 
turtle retina and may be driven in the center of its 
receptive field by luminosity bipolar cells and in its 
surround by amacrine cel ls  with color-opponent 
properties. 
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General background 
Until the 1960s, only a few neurotransmitters 
(acetylcholine, epinephrine, norepinephrine and y- 
aminobutyric acid) were known, and the general belief 
was that the total number of neuroactive substances 
would be relatively small (less than 10). Today, the 
situation is entirely different, and it is now accepted that 
the number of transmitters is much larger, probably 
greater than 50 (Snyder, 1980; Potter et al., 1981). The 
main reason for this increased estimation is the recent 
discovery of a large number of neuroactive peptides: of 
the latter substance P (SP) is probably one of the best 
characterized. Thus our knowledge of SP could serve as 
a model for many other putative neuropeptides (Otsuka 
and Yoshioka, 1993). 
SP is a neuropeptide which forms part of the group 
known as tachykinins. In the past decades, it has become 
firmly established that the tachykinins including SP, 
neurokinin A (NKA) and neurokinin B (NKB), al1 of 
which share the common C-terminal sequence Phy-X- 
Gly-Leu-Met-NH2, are diversely distributed throughout 
the peripheral and central (CNS) nervous system. 
Mammalian tachykinins are found in various organs 
of the body besides the nervous system. However they 
seem to be mostly contained in neurons, released 
therefrom probably upon excitation of the neurons, and 
act on the receptors of target cells to evoke various 
cellular responses (Otsuka and Yoshioka, 1993). Thus 
this mode of function of SP conforms with the definition 
of a neurotransmitter, although the term «neuro- 
modulator» is frequently used in the literature, 
particularly for peptide functions. Since the term 
«neuromodulator» is used to mean various and different 
concepts depending on users (Dismukes, 1979; Krieger, 
1983), we will follow in this review the terminology of 
Potter et al. (1 981) who used «neurotransmitter» to refer 
to «any substance secreted by a neuron to control its 
target cel ls»,  independent of their excitatory or 
inhibitory effects, duration of action, or distance to the 
target cel ls .  Thus we consider S P  to be a neuro- 
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transmitter of the CNS and, as we shall see in this 
review, of particular importance in visual processing in 
the retina. 
Early history of Substance P 
In 1931 von Euler and Gaddum found a substance 
that occurred in equine brain and caused hypotension 
and smooth muscle concentration. Because they used a 
«standard preparation in the form of a dry powder . . .» it 
was conveniently abbreviated to «P»  (Chang and 
Gaddum, 1933). In 1936, its peptide nature became 
known (von Euler, 1936) and during the 50s and 60s 
there were severa1 attempts to purify SP. It was actually 
not finally purified until 1971 when its structure was 
revealed by Leeman and her colleagues (Chang et al., 
1971). 
~ o o n  after the discovery of SP, Dale suggested that 
the chemical transmitter secreted from the peripheral 
ending of a sensory neuron might be the same as the 
transmitter secreted from its central ending (Dale, 1935). 
Dale's statement also suggested that a sensory 
transmitter might be a vasodilator substance, and since 
SP was known to be an endogenous vasodilator it 
became a candidate for a sensory transmitter (Lembeck, 
1953). However, this role was not generally accepted, 
mainly because the lack of evidence of any clear acdon 
of SP on central neurons. The first hint on this issue 
came from Konishi and Otsuka (1971), who in 1971 
found that physalaemin, a substance similar to SP in 
structure and biological activity, exerted an excitatory 
activity on frog's spinal motoneurons. On the basis of 
this expectation, an extract of bovine dorsal root tissue 
was prepared and, a peptide fraction of it was found to 
exert the same excitatory action on frog's spinal 
motoneurons. This peptide was tentatively named 
«dorsal root peptide~, and when it was compared with 
the newly discovered synthetic SP (Tregear et al., 1971) 
it proved to be identical (Takahashi et al., 1974). During 
the following years, data accumulated showing SP to 
fullfil l  the basic criteria for being considered a 
neurotransmitter. 
SP and other tachykinins are active in both the CNS 
and the peripheral nervous system. In general 
tachykinins excite neurons, evoke behavioral responses, 
are potent vasodilators and secretagogues, contract 
(directly or indirectly via release of classical 
transmitters) many smooth muscle and could act as 
arowth factors and as messengers between the nervous 
and the immune systems ( ~ a & i o ,  1988; Felten et al., 
1993). 
Molecular studies have shown an important 
homology among different tachykinins. Therefore, the 
many conclusions about the functional role of SP in the 
mammalian nervous system, largely based on the 
demonstration of SP with immunohistochemistry or 
radioimmunoassay, must be interpreted with caution 
(Maggio, 1988). It is important to realize that some of 
the biological functions thought to be mediated by SP 
may in fact be mediated by another tachykinin. Hence a 
crucial goal is the development of antisera, antagonists. 
and radioligands that are specific enough to discriminate 
between the different mammalian tachykinins. In 
addition, the presence of SP need not imply the presence 
of a receptor for SP at any particular site. Of course both 
the ligand and the receptor are required for activity, 
however there is no apparent correlation across al1 CNS 
regions between the density of SP innervation and the 
density of SP binding sites (Beajouan et al., 1984; Dam 
and Quirion, 1986; Daniel et al., 1989). 
Pharmacological and ligand-binding studies have led 
to the proposal that there are at least three distinct 
tachykinin receptors in mammals (Watling et al., 1994). 
These receptors named NK1, NK2 and NK3 receptors 
have been cloned and sequenced, and shown to be 
members of the G-protein linked superfamily of 
receptors (Guard and Watson, 1991; Nakanishi, 1991). 
thus SP displays highest affinity for NK1 tachykinin 
receptors, whereas Neurokinin A and Neurokinin B bind 
preferentially to NK2 and NK3, however the selectivity 
of these peptides for their preferred receptors is poor, 
and it is possible that their physiological actions would 
be mediated via their interaction with al1 three receptors 
(Watling, 1992). Although most of the effects of SP and 
other tachykinins on the NK1, NK2 and NK3 receptors 
appear to be dependent on their C-terminal, it is also 
possible that SP effects may be related to N-terminal 
directed receptors (Gergathy et al., 1990; Guard and 
Watson, 1991), the presence of yet undiscovered 
subtypes of tachykinin receptors, or to direct activation 
of G-proteins (Mousli et al., 1990). 
Biosynthesis, storage, release, inactivation and 
actions of substance P 
The complete primary structure of S P  and its 
precursor peptides a-, B- and y-preprotachykinin) is now 
known (Kawaguchi et al., 1986; Nakanishi, 1987), as 
well as the mRNAs encoding these three SP precursors. 
Substance P is biosynthetized at the perikaryon where it 
is packaged into vesicles (Fort et al., 1989) and axonally 
transported down to the axon terminals. Immunohisto- 
chemical studies suggest that SP is stored primarily in 
large granular vesicles with diameters of approximately 
100 nm. The terminals containing SP often lack synaptic 
structures though, suggesting nonsynaptic modes of 
release and sites of transmitter action in addition to 
synaptic modes (Barber et al., 1979; Zhu et al., 1986; 
Matthews et al., 1987; Ribeiro-Da-Silva et al., 1989). 
Action of S P  is terminated by inactivation 
mechanism. Severa1 enzymes like enkephalinase (Tumer 
et al., 1985), acetylcholinesterase (Chub et al., 1980) and 
some SP-degrading endopeptidases (Lee et al., 1981; 
Laufer et al., 1985; Endo et al., 1988) as well as uptake 
mechanisms (Nakata et al., 1981) seem to be involved in 
this inactivation. Usually SP produces membrane 
depolarization of slow time course in neurons and 
smooth muscle fibers. The main mechanism is probably 
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a decrease of potassium conductance (Minota et al., 
1981; Fujisawa and Ito, 1982). Stanfield and coauthors 
(1985) and Masuko and coworkers (1986) have shown 
that SP  raises neurona1 membrane excitability by 
reducing inward rectification of potassium channels. 
Other effects of SP on postsynaptic membranes such as 
inhibition of muscarine-sensitive potassium current, 
inhibition and activation of calcium-activated potassium 
current, activation of calcium, and activation of sodium 
current have al1 been reported (Otsuka and Yoshioka, 
1993). These effects of SP may also contribute to the 
generation and regulation of depolarization. Although in 
general the action of SP  lasts between 10-20 sec 
(Dougherty et al., 1993), faster responses having a 
duration of 1-10 sec have also been observed upon short 
pulse iontophoretic or pressure application of SP  
(Hanani and Bumstock, 1984; Konishi et al., 1989). The 
membrane depolarization evoked by SP  induces an 
elevation of intracellular calcium ion concentration. 
Thus SP appears to increase calcium through both the 
release of calcium from intracellular stores (Matthews et 
al., 1989) and the influx of extemal calcium (Matthijs et 
al . ,  1990), probably mediated through inositol 
phospholipid hydrolysis (Merrit and Rink, 1987). 
Molecular cloning studies have also shown the 
involvement of G proteins in SP actions. 
coexistence of SP with other neurotransmitters 
Until the 1970s it was generally believed that a 
neuron contained and released only one transmitter. 
However, the possibility that a neuron contained 
more that one neurotransmitter substance was 
strongly advocated in the late 1970s by the observations 
of Chan-Palay et al. (1978) and Hokfelt et al. (1978) 
that SP  and serotonin coexisted in neurons of the 
rat's CNS. Nowadays we know of a great many 
examples of coexistence of SP with other putative 
neurotransmitters and related substances such as 
Choline Acethyltransferase (Vincent et al., 1983), 
GABA (Kosaka et al., 1988; Pourcho and Goebel, 
1988a,b; Vaney et al., 1989), Tyrosine Hydroxylase 
(Kosaka et al., 1988), 5-Hydroxytryptamine (Chan- 
Palay et al., 1978; Hokfelt et al., 1978; Chiba and 
Masuko, 1989; Halliday et al., 1988), glutamic acid 
and other excitatory amino acids (Battaglia and 
Rustioni, 1988; Dougherty et al., 1993), Neurokinin 
A and Calcitonin gene-related peptide (Lee et al., 
1985; Cameron et al., 1988), Somatostatin (Murakami 
et al., 1989), Bombesin (Cameron et  al. ,  1988), 
Enkephalin (Tashiro et al., 1989, Dynorphin (Anderson 
and Reiner, 1990), Corticotropin-releasing factor 
(Crawley et al., 1985; Hokfelt et al., 1994) and other 
newly discovered messengers such as Nitric 
Oxide (Hokfelt et al., 1994). However the functional 
significance of the coexistence of more than one 
neurotransmitter is still not fully understood (see Otsuka 
and Yoshioka [1993] for a recent review on these 
issues). 
Function of Substance P 
A wealth of evidence supports the involvement of 
SP in a variety of biological activities such as: pain 
transmission, vasodilatation and increase in capillary 
permeability, smooth muscle contraction, motor and 
secretory control of peripheral organs such as the 
intestines and the salivary glands, control of respiratory, 
cardiovascular, autonomic and endocrine functions, 
activation of the immune system, and neurogenic 
inflamation and memory processings (Pernow, 1983; 
Maggio, 1988; Otsuka and Yoshioka, 1993; Felten et al., 
1993). 
Substance P and neurodegenerative disease 
SP is implicated in many psychoneurological 
diseases such as Huntington'disease, Parkinson's 
disease, schizopherenia, Alzheimer's disease, Riley- 
Day-syndrome, Hirschprung's disease, allergy, rhinitis 
and chronic urticaria, arthritis, headache, Herpes zoster, 
carcinoid syndrome and others (Leake and Ferrier, 1993; 
Kowall et al., 1993; Otsuka and Yoshioka, 1993). The 
causes of the neurodegenerative disorders of Parkinson's 
disease. Alzheimer's disease and amyotrophic lateral 
sclerosis are unknown. It is proposed that al1 these 
disorders result primarily from a loss of trophic 
peptidergic neurotransmitter, possibly SP (Barker, 1991). 
Constantidinis et al. (1983) have found that destruction 
of dopaminergic cells produces an increase of SP in 
substantia nigra, thus indicating the inhibitory action of 
dopamine on this peptide. In Huntington's disease, 
decreased SP levels are found in the pars reticulata and 
pars compacta in the substantia nigra (90%), in the 
glomus pallidus (80%) and in the putamen (70%) 
(Kanazawa et al., 1988). On the other hand, an increase 
of SP has been suggested to occur in these brain areas in 
patients with schizophrenia (Rimon et al., 1984). 
Morphology of SP containing amacrine cells in the 
retina 
In the vertebrate retina, SP-IR is primarily found in 
classes of amacrine cells (Karten and Brecha, 1980; 
Brecha et al., 1982; Brecha and Karten, 1983, 1985; 
Pourcho and Goebel, 1988a; Brecha and Stemini, 1989; 
Cuenca and Kolb, 1989; Marshak, 1989; Vaney et al., 
1989). Figures 1 and 2 show camera lucida drawings of 
the different morphologies of SP-IR amacrine cells in 
vertebrate retinas. In most species SP-IR amacrine cells 
have their cell bodies located either in the inner nuclear 
layer (INL) or in the ganglion cell layer (GCL), and their 
dendrites are monostratified in the middle to lower strata 
of the inner plexifonn layer (IPL) (the IPL is commonly 
divided into 5 equal thickness strata or sublayers as was 
first described by Cajal, 1892) (Fig. 1, toad, Type B cell 
in turtle). In some species such as the tiger salamander, 
bullfrog, and turtle, SP-IR is also seen in bistratified or 
multistratified cells (Fig. 1, turtle Type A cell; tiger 
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salamander) (Brecha and Karten, 1985; Yang and small somata and small-field, monostratified dendritic 
Yazulla, 1986; Cuenca and Kolb, 1989). Reptiles (i.e. trees restricted to a plane of branching in S3 (Fig. 1) 
lizards and turtles) seem to be rather unique in having (Cuenca and Kolb, 1989; Hiscock and Straznicky, 1989). 
two quite morphologically distinct types of amacrines In most mammalian retinas only one type of SP 
cell containing SP. Type A amacrine cells have large amacrine cell is consistently seen but other subtypes 
somata and wide-field, tristratified dendritic trees in have been described, which may have been classified as 
strata 1,  3 and 5 of the IPL while Type B cells have separate from the single type due to confusions of 
Fig. 1. Camera 
lucida drawings of 
SP-IR amacrine 
cells in the toad, 
turtle and tiger 
salamander, as 
seen in wholemount 
views. Turtle has 
two types of SP-IR 
amacrines: Type A 
and Type B. Toad 
cells from Hiscock 
and Strasnicky 
(1989). Scale bar= 
200 pm. Turtle cells 
from Cuenca and 
Kolb (1989). Scale 
bar= 40 pm. Tiger 
salamander cells 
from Yang and 
Yazulla (1986). 
Scale bar= 20 pm. 
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dendritic stratification levels.  For  example,  two the S314 border or in S4  of the IPL (dependent on 
subpopulations of amacrine cells containing SP have author) (Fig. 2, cat) (Pourcho and Goebel, 1988a; Vaney 
been described in the cat retina. One cell was reported as et al., 1989). The other type was said to be bistratified 
a monostratified amacrine with processes ramifying on with processes in S1 and S4  (Pourcho and Goebel, 
Fig. 2. Camera lucida 
drawings of SP-IR 
amacrine cells in the 
human and cat. 
Human cells from 
Cuenca et al. (1995). 
Scale bar= 10 pm. 
Cat cells from 
Pourcho and Goebel 
(1988a). Scale bar= 
50 pm. In human 
retina, the top cell is 
displaced (dis) to the 
GCL, and both have 
axon-like procese 
(ax). In the cat, the 
right hand cell is 
displaced to the GCL. 
Substance P in the retina 
Fig. 3. a. Light micrograph of a SP-IR amacrine cell in human retina. Large arrow points to claxon-like,> processes. Small arrows point to spines on the 
primary dendrites. b. Light micrograph of SP-IR arnacrine cells in cat retina. Frorn Vaney et al. (1989). Scale bar= 20 pm in both a and b. 
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1988a). As discussed in Vaney (1990) it is not clear Pourcho and Goebel's paper (1988a) shows them in Fig. 
whether these might not actually be the same cell type 2. In Fig. 3b, a picture of a population of SP-IR amacrine 
but differences in intensity of staining led to  the cells, as seen in a wholemount micrograph from Vaney 
appearance or non-appearance of S1 processes (Vaney et and coauthors work (1989), can be compared. Rather 
al., 1989). The morphology of the so called mono-or obviously the two publications are showing the same cell 
bistratified cells in cat are very similar. A drawing from type yet the authors give them the slightly different 
Fig. 4. a. Light micrograph of a SP-IR amacrine cell in a vertical section of human retina. The SP cell is norrnally placed in the INL and its rnajor 
dendritic branching is in S3 of the IPL. b. Light rnicrograph of an SP-IR amacrine cell in a vertical section of hurnan retina, with its cell body displaced to 
the GCL. The rnajor dendritic branching is in S3 like the cell above. Srnall arrows point to spines on the major dendrites. Scale bar= 20 prn. 
Substance P in the retina 
descriptions. 
In the rabbit retina two types of SP-IR amacrine 
cells have been described: a monostratified amacrine 
ramifying in S5 of the IPL, and a multistratified 
amacrine with processes running in S1, S3  and S5 
(Brecha and Sternini, 1989). Again it is possible that the 
description of a monostratified amacrine of S5 could 
have been interpreted from a partial section of a 
multistratified cell where the S5 ramifying dendntes are 
confused with an intensely stained SP-IR ganglion cell 
(see later section on SP-IR ganglion cells) Two 
subpopulations of SP-IR amacrine cells have been 
reported in the rat retina as well. These cells have 
somata in either the INL or the GCL. It is unclear 
whether these have different morphologies although they 
do appear to have topographical differences in 
distribution. The SP-IR cells of the GCL are limited to 
the superior temporal region while the SP-IR cells in the 
INL are found throughout the retina (Zhang and Yeh, 
1992). However, the exact differences in branching 
pattems or overall morphologies of these two different 
cell types, if they are indeed different, is not yet well 
documented. 
Even more confusion arrives when we consider SP- 
containing amacrine cells in the monkey and human 
retinas. In monkey retina the perikarya of the SP-IR 
amacrine cells have been described as being located in 
the proximal row of the INL, the middle of the IPL or in 
the GCL (Brecha et al., 1982). They are described as 
three different amacrine cell types with immunostained 
processes in three plexi in the IPL. In addition because 
SP-IR processes pass to the OPL and optic nerve fiber 
layer, SP-IR interplexiform cells and ganglion cells are 
claimed to be present (Brecha et al., 1982; Marshak, 
1989). They may in fact al1 be variations of the same cell 
type and interpretations of differences may arise when 
viewing sectioned immunostained material as compared 
wholemounts. 
A few authors have described SP-IR in the human 
retina (Tomqvist and Ehinger, 1988; Li and Lam, 1990) 
and their descnptions are essentially the same as those 
for monkey SP-IR amacrine cells. We have recently 
repeated immunocytochemical staining for SP in human 
retina and have obtained further information on 
morphology and neurocircuitry of these cells (Cuenca et 
al., 1994, 1995). In the human retina we have seen 
intensely stained, wide-field, large-bodied, amacrine 
cells to be SP-IR (Figs. 2, 3a, 4, 5). We interpret there to 
be only one morphological type. They can be displaced 
to the GCL or normally placed in the INL and stratify 
predominantly in S3  of the IPL (Fig. 4a,b). Their 
primary dendrites in S3 are studded with spines (Figs. 
3a, 4a,b, small arrows). These SP-IR amacrines also 
have a few processes in S1 and some even pass into the 
OPL (Fig. 5a). In addition, they al1 appear to emit 
«axon-like» processes that run in S3 and S5 and into the 
nerve fiber layer to end on blood vessel walls (Figs. 2a, 
5b). By light microscope observation, the SP-IR 
amacrine look as though they communicate directly with 
unstained amacrine cell bodies and with SP-IR ganglion 
cells (see later section) via a network of fine IR 
processes. These SP-IR amacrine cells in human retina 
correspond most closely in morphology to a wide-field 
thorny type 2 amacrine cell, described and classified in 
Golgi studies (Mariani, 1990; Kolb et al., 1992). 
In terms of development, SP appears in amacrine 
cells in the human retina around 14 weeks of gestation 
(Jotwani et al., 1994) although, they may be present in 
the outer neuroblastic layer even as early as 10 weeks of 
gestations (Yew et al., 1991). SP thus appears early in 
development of the vertebrate retina and might help 
shape connections of the IPL in a growth factor role. 
Alternative or additionally, SP could be a secretagogue 
to the retinal vasculature as is suspected of SP fibers in 
other parts of the CNS (Wahl, 1985; Maggio, 1988). 
Indeed, Ye and coauthors (1990) studied specifically the 
peptidergic innervation of the vasculature of the optic 
nerve and retina in both rhesus monkey and rat. They 
found severa1 peptidergic immunoreactive fibers 
including SP in the adventitia and perivascular space, 
along the course of the central retinal artery within the 
optic nerve and some in the lamina cribosa. However, 
they did not find immunoreactivity in the retinal 
arterioles nor stain well the SP-IR neurons (Ye et al., 
1990). In the human retina, we find, the SP-IR amacrines 
themselves to emit long, fine processes that loop back 
and forth over blood vessels in the GCL and even 
terminate against blood vessel walls and in Müller cell 
end feet close to blood vessels (Cuenca et al., 1995). 
Electron microscopy of SP-IR amacrine cells has 
been performed in goldfish (Yazulla et al., 1985), in 
monkey (Marshak, 1989) and in human (Cuenca et al., 
1994). Some aspects of neurocircuitry of these cells has 
been demonstrated by these studies. Processes of SP-IR 
amacrine cells in goldfish and monkey retina make 
conventional synaptic contacts onto both amacrine and 
ganglion cell processes and receive synaptic input from 
amacrine and bipolar cells (Yazulla et al. ,  1985; 
Marshak, 1989). Our own studies confirm these findings 
as can be seen in Figure 6. In Figure 6a, two SP-IR 
amacrine cell processes are postsynaptic to a cone 
bipolar axon terminal in S3 of the IPL (CB with a 
synaptic ribbon). SP-IR processes are primarily 
postsynaptic to unspecified amacrine cell processe (Fig. 
6b,  A,  arrows) but also to other SP-IR amacrine 
processes (not shown). The output of SP-IR amacrine 
cells is to ganglion cell dendrites (Fig. 6c, GC)? other 
unspecified amacrine cells and reciprocal to their input 
bipolar axons. 
Some of the input amacrine cells to SP-IR cells may 
be excitatory from ACh containing neurons in the retina. 
We say this because, in the rabbit retina, infusion of 
exogenous acetylcholine (ACh) into the vitreal chamber 
leads to an increase in the amount of SP immuno- 
reactivity in the retina (Goebel and Pourcho, 1992) 
suggestive of synaptic interactions between ACh and SP 
amacrine systems. We shall have to await further studies 
to confirm these putative connections. 
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Density and distribution of SP-IR amacrines in the population, comprised e n t i r e l ~  of the T Y P ~  B SP-IR 
vertebrate retina cells, peaked in density in the visual streak temporal to 
the optic nerve at 250 SP-IR cells per mm2. The 
SP-IR amacrine cells occur at quite high density in distribution appeared to fa11 off uniformly in elliptical 
the vertebrate retina particularly in comparison to isodensity lines parallel to the visual streak until a 
dopaminergic amacrine cells. But their density is d e n s i t ~  of 50  cells Per mn2 was reached in far 
typically less [han cholinergic amacrine cells (Vaney, peripheral retina. We estimated that the total number of 
1990). In tu&, we found that the Sp-IR amacrine cel] SP-IR amacrine cells in turtie retina to be 7000. Of these 
Ta 
, INL 
Fig. 5. Light micrographs of a vertical section of 
human retina immunostained with SP. a. SP-IR 
process passes from an S1 running process in 
the IPL to the OPL to end in a large varicosity 
(arrows). Most SP-IR dendrites run in S3 but 
some processe run down in S5 as well. INL: 
inner nuclear layer. b. SP-IR process passes 
down from the IPL to end as a varicosity on a 
blood vessel wall (bv) (arrow). Scale bars= 
20 pm. 
956 
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Fig. 6. Electron micrographs of SP-IR amacrine cell synapses in the human retina. a. Two SP-IR amacrine processes (1 and 2) are postsynaptic at a 
ribbon in a cone bipolar axon terminal (CB) in S3 of the IPL. Process 3 is probably postsynaptic to process 2. Process 2 is postsynaptic to a non- 
reactive amacrine profile (A, arrow). b. An SP-IR amacrine profile is postsynaptic to a cluster of non-reactive amacrine cell profiles (As, arrows). c. SP- 
IR processes are making synapse (white arrows) upon a large diameter ganglion cell dendrite (GC). Scale bar a, c is 1 pm but for b is 0.5 pm. 
Fig. 7. Light micrographs of SP-IR ganglion cells in the turlle retina. a. SP-IR ganglion cell bodies, sorne of which are large diameter and have IR in 
their prirnary dendrites, can be seen. b. A microelectrode filled with lucifer yellow and neurobiotin approaches an FlTC fluorescent SP-IR ganglion cell 
body and both ionophores are passed into the SP-IR cell body. c. The ganglion cell as seen in wholernount after staining with neurobiotin, and 
incubation with peroxidase-conjugated streptavidin and HRP histochernistry. It has a beautiful large-field dendritic tree that stratifies in S1 of the IPL. 
Scale bars 25 prn in a and b and 50 prn in c. Frorn Fernandez and Kolb. (1 993). 
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7000 ceh ,  0nly 250 were tbougbt to be Type A cells. 
The latter were found only in the peripheral retina and 
were not present in the linear visual streak at al1 (Cuenca 
and Kolb, 1989). 
Vaney and colleagues (1989) found SP-IR amacrine 
cells in cat retina to have a density of 500 cells/mm2 in 
the area centralis declining to a density of 25 cells/mm2 
in the peripheral retina. In cat like in human, the 
population of SP-IR amacrine cells is divided into 
normally placed cells in the INL and displaced cells in 
the GCL. The displaced cells predominate as 90% of the 
SP-IR amacrines in peripheral cat retina, but displaced 
and normal appear to occur  in equal numbers at 
maximum density in the cat area centralis (Vaney et al., 
1989). Cat retina apparently has as many as 39,000 SP- 
IR amacrine cells. 
Similar total counts of SP-IR cells have not yet been 
possible in human retina (Cuenca et al., 1995). However, 
even with limited data, we have counted 35 cells/mm2 
SP-IR amacrine cells in an area 5-9 mm temporal 
superior from the fovea and 9 SP-IR amacrine cells/mm2 
in area 12- 15 mm inferior temporal from the fovea. Thus 
the density distribution may be very similar in human 
and cat retinas, but taking into consideration the larger 
area of the hurnan retina and the increased cell density at 
the fovea compared with the area centralis of the cat, it is 
likely that human has a larger total number of SP-IR 
amacrine cells. Again like in cat, in human, displaced 
SP-IR amacrines outnumber normally placed (59:41 for 
the central retinal piece and 71:29 for  the more 
peripheral retinal piece) (Cuenca et al., 1995). Unlike cat 
though, our nearest neighbor analysis on human retina 
indicates the SP-IR amacrine cells lie in a close to 
random mosaic. It seems, however, that the irregularities 
in the amacrine mosaic are caused by the frequent 
occurrence of pairs of SP-IR amacrine cells with 
intervening longer distances to others. 
Rabbit, apparently has a very large number of SP-IR 
neurons too, but it is not clear exactly which proportion 
of them are amacrine cells and which are ganglion cells. 
There are supposedly 1,000-1,400 SP-IR cells/mm2 in 
the linear visual streak of this retina with a fa11 off to 
125-200 cells/mm2 in the peripheral retina (Brecha et al., 
1987). The majority of the SP-IR cells lie in the GCL in 
rabbit. After optic nerve section the number of SP-IR 
cells are reduced by 90% in the visual streak and 45- 
60% in the peripheral retina. This equates to a density of 
SP-IR amacrine cells at the visual streak of 
approximately 120 cells/mm2 and in the peripheral 
retina of approximately 90 cells/mm2. Counts like these 
lead to the conclusion that a very high proportion of 
amacrine cells, and an even higher proportion, relative to 
other animals, of ganglion cells in rabbit retina use SP in 
a neurotransmilter role. 
SP-IR ganglion cells 
In turtle, frog, bird, rabbit and human retinas there is 
evidence for certain ganglion cells to immunostain for 
SP (Karten and Brecha, 1980, 1983; Kuljis and Karten, 
1982; Brecha et al., 1982, 1984, 1987; Ehrlich et al., 
1987; Cuenca and Kolb, 1989; Fernandez and Kolb, 
1993; Cuenca et al., 1994). A subpopulation of ganglion 
cells that are displaced in the pigeon retina also seem to 
be specific for SP (Britto and Hamassaki, 1991). They 
may be the large cells of the amacrine cell layer 
described by Dogiel and referred to in Caja1 (1892). The 
most positive evidence for a ganglion cell being SP-IR 
comes from studies of the rabbit retina. Brecha and co- 
workers (1987) showed that after optic nerve section, the 
SP-IR cells in the GCL,  that branched in SS, 
disappeared. Furthermore retrograde tracing studies with 
Fast Blue from the superior colliculus revealed SP-IR 
ganglion cell bodies to be double stained. These SP-IR 
ganglion cells are estimated to form 25-35% of the total 
number of ganglion cells in the rabbit retina. They 
project to the superior colliculus, dorsal lateral 
geniculate body and the accessory optic nucleus (Brecha 
et al., 1987; Brecha and Sternini, 1989). 
Two types of SP-IR cell bodies are stained in turtle 
retina in our hands (Cuenca and Kolb, 1989; Fernandez 
and Kolb, 1993). (Fig. 7a). The smaller-bodied one is 
less intensely SP-IR than the larger and little information 
is available on its morphology. However, the large SP-IR 
ganglion cell in turtle has often enough immuno- 
reactivity in the major dendrites that it can be seen to 
branch in S1-2 of the IPL and to bear an axon, so 
positively identifying it as a ganglion cell. Figure 8a 
shows the appearance of such SP-IR ganglion cells in 
wholemount preparations of turtle. With a technique of 
immunostaining for SP (Fig. 7a) and then intracellular 
injection of neurobiotin through a microelectrode into 
SP-IR cell bodies in wholemounts of turtle retina (Fig. 
7b), we have been able to discover the exact morphology 
of one of the large-bodied SP ganglion cell types in 
turtle retina (Fernandez and Kolb, 1993). Thus in Figs. 
7c, 8b,c such a SP-IR ganglion cell is fully revealed. 
Originally we considered this ganglion cell to be the 
G20 of the Golgi study (Kolb, 1982; Cuenca and Kolb, 
1989; Fernandez and Kolb, 1993) however, with our 
latest evidence from intracellular dye injection and 
retrograde tracing studies, we are now convinced that 
this particular SP-IR ganglion cell is in fact a G18 cell 
type (Kolb,  1982: Zhang and Eldred, 1994; 
Ammermüller et al., 1995). Its dendrites branch on a 
plane in S1 to S112 border (Fig. 8c) and the tree consists 
of coarse, crenulated dendrites with curving side 
branches filling in between main dendrites. It has a large 
cell body (22 pm diameter) and a 300-500 pm dendritic 
tree diameter. Many of this kind of cell are displaced in 
turtle retina, and considered to be Dogiel cells (Kolb. 
1982; Zhang and Eldred, 1994), although the one 
intracellularly stained with neurobiotin (Figs. 7b, 8b,c) 
was not (Fernandez and Kolb, 1993). SP-IR G18 cells 
project exclusively to the nucleus of the basa1 optic root 
in the turtle (Zhang and Eldred, 1994). 
We have also immunostained a ganglion cell type 
with SP in the human retina (Cuenca et al.. 1995). Figure 
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Fig. 8. Camera lucida 
drawings of an SP-IR 
ganglion cell and major 
dendrites as seen in 
wholemount. The axon 
is immunostained for 
some distance (arrow). 
From Cuenca and Kolb 
(1 989). Scale bar= 
40 pm. b. Camera lucida 
drawing made by the 
Eutectics neuron tracing 
system of the 
neurobiotin stained SP- 
IR ganglion of Fig. 7. 
c. Vertical rotation of the 
Eutectics drawings in b. 
Scale bar for b and c is 
100 pm. 
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9 S ~ O W S  such a cell in a whoiemount view of peripheral 
human retina. It appears as a lightly SP-IR cell body of 
large diameter (22 pm) and with immunoreactivity 
spreading only into the major dendrites. However, 
focusing up and down on the immunostained cell and its 
dendrites, we can determine that the main branches are 
in the same IPL stratum as the SP-IR amacrine cells 
primary dendrites. The more intensely stained fine 
processes are from the SP-IR amacrine cells as they 
wrap around the SP-IR ganglion cell body and its 
primary dendrites (Fig. 9, arrows). Electron microscopic 
observation will be needed to determine whether these 
fine processe and boutons are synaptic upon the SP-IR 
ganglion cell body or not. The size of the cell body and 
the branching leve1 of the dendrites in S3, suggest that 
this human SP-IR ganglion cell is a G21 (Kolb et al., 
1992). In turtle too, we noticed the same apparent 
interaction between SP-IR amacrine cells (in this case it 
Fig. 9. Light micrographs at two 
different planes of focus on an SP- 
IR ganglion cell in human whole- 
mount retina. In a. The focus is on 
the cell body of the ganglion cell, 
and fine intensely SP-IR processes 
from amacrine cells run across the 
top of the cell body and over the 
primary dendrites. b. The cell at a 
plane of focus underneath the cell 
body where the SP-IR amacrine 
processes can still be seen running 
over the lower surface of the cell 
body. Arrows point to small 
intensely IR boutons of the 
amacrine cell fibers. Scale bar= 
20 pm. 
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was the tristratified, Type A SP amacrine, Fig. 1) and 
ganglion cell bodies, both SP-IR and non SP-IR. Like in 
human, processes from the SP-IR amacrine cells in turtle 
wrap around ganglion cells, and end in clusters of 
boutons on ganglion cell somata, often far from the 
immunostained cells of origin (Cuenca and Kolb, 1989). 
This long-range interaction is particularly evident in 
turtle because the SP-IR Type A cell bodies are found in 
the peripheral retina, avoiding the linear visual streak, 
while their bouton endings are very noticeable on 
ganglion cells of the visual streak. 
Substance P in the optic nerve 
Some proportion of optic nerve fibers have been 
shown to be SP-IR in the different species where SP-IR 
ganglion cells have been suspected (Kuljis and Karten, 
1982; Kuljis et al., 1984; Brecha et al., 1987; Ehrlich, 
1987; Cuenca and Kolb, 1989). SP fibers from the retina 
are found to terminate in the optic tectum in anurans 
(Kuljis et al.,, 1984) but in the superior colliculus, dorsal 
lateral geniculate and the suprachiasmatic nucleus (SCN) 
of the accessory optic system in rabbit (Brecha et al., 
1987; Takatsuji et al., 1991). This nucleus has been 
identified as a pacemaker for many circadian activities in 
mammals. SP apparently produces shifts in spontaneous 
activity in neurons of the SCN with a phase response 
curve that is similar to the effect of light pulses to the 
eye under constant darkness. In effect SP may be a 
transmitter for signals conveying environmental light- 
dark information from the retina to the SCN (Shibata et 
al., 1992; Shirakawa and Moore, 1994). In this respect, it 
is also interesting to note that SP-IR fibers have been 







cells in the turtle 
retina that have the 
morphology of SP- 
IR Type B (A30, top 
cell) and type A 
(A31, bottom cell) 
amacrines in the 
turtle retina. Both 
cells' physiological 
responses to A) 
spots and annuli of 
light and to B) 
colored and C) an 
intensity series of 
stimuli are shown. 
See text for full 
descriptions. From 
Ammermüller and 
Kolb (1 995). Scale 
bar 25 pm for A30 
and 50 pm for A31. 
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lizard (Engbretson et al., 1982). 
Co-localization of substance P and other neuroactive 
substances in the retina 
There is strong evidence for colocalization of SP and 
other neurotransmitters in the vertebrate retina. Thus, 
SP-IR amacrine cells also exhibit GABA-like immuno- 
reactivity in the cat retina (Pourcho and Goebel, 1988b; 
Vaney et al., 1989). In larva1 tiger salamander retina one 
population of SP amacrine cells also express GABA-IR 
(Watt et al . ,  1993, 1994). In addition GABA-IR 
colocalizes in some of the SP-IR amacrine cells in 
another anuran retina, that of the toad, Bufo marinus 
(Main et al., 1993). 
Also in larva1 tiger salamander retina one population 
of the SP-IR amacrine cells expresses glycine immuno- 
reactivity and glycine high-affinity uptake (Watt and 
Florack, 1993). In contrast, there is no evidence for co- 
localization of glycine and SP in goldfish retina (Yazulla 
and Studholme, 1990). Mammalian SP-IR amacrines 
have not been tested for colocalization with glycine. It is 
almost certain that SP-IR cells in mammals do not 
colocalize ACh (Vaney, 1990). The morphology of the 
ACh «starburst» amacrine cell and the SP-IR amacrine 
cells is entirely different although the type b «starburst» 
cells do stratify in the same IPL stratum and thus they 
could very well talk to each other synaptically. 
Physiological role of SP-IR neurons in the turtle 
retina 
Since the SP-IR amacrine cells in the turtle are either 
monostratified in S 3  of the IPL at the border of 
sublaminas a and b (sublamina a is thought to be the 
portion of the IPL neuropil where OFF-center ganglion 
cells are driven and sublamina b, where ON-center 
ganglion cells are driven (Nelson et al., 1978); we know 
that the ON/OFF border is in S3 in the turtle retina 
(Ammermüller and Kolb, 1995)) or tristratified with 
dendrites in both ON and OFF strata, one would predict 
that they would be «ON-OFF» responding neurons. 
Ammermüller  and Kolb (1995) have recently 
intracellularly recorded and morphologically stained 
most of the known neurons of the turtle retina. Amongst 
the numerous physiological types, the three cells that are 
SP-IR in the turtle retina can be recognized. Thus, for 
the first time now, we have some information on the 
physiological response characteristics of neurons that 
may use SP as a neurotransmitter and test the prediction 
of response type. 
The small-field, monostratified Type B SP-IR 
amacrine cell (see Fig. 1) corresponds in morphology 
and stratification leve1 to an amacrine cell given the 
name A30 (Ammermüller and Kolb, 1995). Figure 10 
illustrates the intracellular lucifer stain of an A30, whose 
physiological responses to light spots and annuli of 
various wavelengths and intensities are shown in the 
neighboring panel. A30's response consisted of a large 
depolarizing transient at light ON and another smaller 
transient at light OFF for al1 stimulus parameters used 
(Fig. 10, A30, A, B and C). This is a typical ON-OFF 
neuron of the retina. There was no antagonistic surround, 
as stimulation with an annulus (A, lowest trace) did not 
show any sign reversal of the response. Responses to al1 
the three colored stimuli were equal and thus the A30 
was not color-coded in any way (Fig. 10, A30, B). The 
dynamic range was quite flat ,  since the response 
amplitude increased steadily over the whole range of 
intensities used (5 log units) (Fig. 10, A30, C). 
The A31 of figure 10. is considered to be the SP-IR 
Type A amacrine cell of turtle (compare Fig. 1, Type A 
and A3 1 in Fig. 10). The A3 1 is labeled as having wide- 
ranging dendrites in S1 and S5 but this was a far 
peripheral cell with a very large dendritic field size (1 
mm diameter) and the dendrites started in S1 from the 
cell body position and descended to S5 to run for 600 
pm. The dendrites branched sparsely and bore a few 
appendages. Some of the dendrites then migrated back 
up to S1 to run therein for severa1 more 100 pm (Fig. 
19a). The whole dendritic tree covered a 700 pm 
diameter field (Fig. 11) and many of the dendrites 
occupied S3  of the IPL, for much of the time. The 
beaded and appendage-bearing aspect of the terminal 
dendrites in S5 and the manner of passing up and down 
between S1 and S5 are particularly characteristic of the 
SP-IR Type A cells (Cuenca and Kolb. 1989) and 
convince us that this is the same cell type. Like SP-IR 
A30, A3 1 was an ON-OFF cell (Fig. 10, A31, A). 
However, unlike A30, an increasing spot size drastically 
reduced the amplitudes of both the ON and the OFF 
transient, indicating an inhibitory surround although no 
clear response sign reversal could be obtained with the 
annulus (Fig. 10, A3 1, A lowest trace). The responses to 
red and blue were sustained ON while green elicited a 
pronounced OFF transient (Fig. 10, A3 1, B). This may 
suggest some degree of color sensitivity. In the intensity 
series, low intensities produced sustained responses, 
while OFF transients appeared at higher intensities (Fig. 
10, A31, C). Fast transients were superimposed on the 
slow potentials in al1 the responses. Thus A31. SP-IR 
Type A cell, seems to be a more complicated ON-OFF 
amacrine cell type than A30. Its physiology reflects the 
wide-field nature of the cell and its responses suggest 
dendritic spiking mechanisms are at play. A31 probably 
has a role in transferring activity across long distances in 
the retina and possibly controlling ganglion cell activity, 
including SP-IR ganglion cells, right at the latters cell 
body, by means of the encircling synaptic boutons. 
The SP-IR ganglion that is the G18 type has also 
been intracellularly recorded (Ammermüller et al., 
1995). An example of a G18 is shown in Fig. 1 l .  As can 
be seen it has a remarkable similarity to the injected cell 
that had an SP-IR cell  body in Figs.  7 ,  8 .  The  
intracellularly recorded G 18 had a dendritic tree 
measuring 600 pm across that stratified narrowly in S1 
(Fig. 11). The cell gave OFF-center type responses to 
light spots  but use of an annulus revealed an 
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Fig. 11. lntracellularly stained 
and recorded G18 in the turtle 
retina. G18 has the same 
morphology as the SP-IR, 
intracellularly- and neurobiotin- 
stained, SP-IR cell of Figs. 7b 
and 8b. The physiological 
response to A) white l ight 
spots, B) colored spots and C) 
colored annuli are shown. See 
text from more details. From 
Ammermüller et  al. (1995). 
Scale bar= 25 pm. 
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antagonistic, sustained depolarizing surround (Fig. 1 1 ,  
A, lowest trace). Red. green and blue small spots were 
al1 hyperpolarizing, non color-coded (Fig. 1 1 ,  B) .  
However, red and green annuli stimulating the surround 
(Fig. 11, C) produced sustained depolarizations, while 
blue annuli produced sustained hyperpolarizing (OFF) 
responses (Fig. 8C). This suggests that G18, one of the 
putative SP-IR ganglion cells, is driven in the center of 
its receptive field by luminosity (non color-opponent) 
bipolar cells and in its surround by amacrine cells with 
color-opponent properties. 
In other species as well as in the turtle, physiological 
studies demonstrate that the application of SP to the 
retina has a direct excitatory action upon most  
physiological varieties of ganglion cells (Dick and 
Miller, 1981; Glickman et al . ,  1982; Downing and 
Djamgoz, 1983; Zalutsky and Miller, 1990). SP action is 
not restricted to only SP-containing ganglion cell 
varieties. For example, application of 1 pm substance P 
causes a slow and prolonged increase of background 
activity in various ganglion cells of the fish retina 
(where no SP-IR ganglion cell have yet been reported) 
and an enhancement of NON» and «OFF» components of 
light-evoked responses (Glickman et al., 1982; Downing 
and Djamgoz, 1983). In the turtle retina, SP causes a 
general elevation of the excitable components of al1 
ganglion cell types recorded and, in particular, increases 
spontaneous activity (Adolph, 1989). 
Substance P has a strong excitatory effect on 
ganglion cells of mammalian retinas too. Such can be 
a CONTROL 
seen in Fig. 12b.c where SPs action on a brisk sustained 
and a transient ON-OFF directionally selective ganglion 
cell of the rabbit retina is documented (Zalutsky and 
Miller, 1990). In the ON-center brisk sustained ganglion 
cell: SP greatly increases the spontaneous activity but 
does not noticeably affect the light response. SPs effect 
on the ON-OFF directional cell is to dramatically excite 
the cell with a huge increase in spontaneous activity 
after the termination of the light response (Fig. 1 lc).  
According to Zalutsky and Miller's data, 15% of the 
rabbit ganglion cells are strongly excited and 60% show 
a moderate to large increase in spontaneous activity. 
These authors also found that SPs excitatory actions 
were limited to neurons of the inner retina, in the rabbit. 
Thus horizontal cells were not affected. They conclude 
that SP amacrine cells are playing a role in modulating 
the excitability of inner retina1 neurons locally, and are 
probably not contributing to the actual receptive field 
organization of the ganglion cells (Zalutsky and Miller, 
1990). 
Whether the action of SP is a direct one via release 
of transmitter from SP-IR amacrine processes upon 
ganglion cell dendrites and cell bodies, or whether there 
is a feedback loop through bipolar cells thereby affecting 
ganglion cells secondarily, is not completely clear. 
Electron microscopy indicates that bipolar cells receive 
extensive synaptic feedback synapses from SP- 
containing amacrine cells in both goldfish and human 
retina (Yazulla et al., 1985; Cuenca et a l . ,  1994). 
Furthermore, physiological evidence indicates that 
DURING SUBSTANCE P 
BEFORE DURING SUBSTANCE P AFTER 
4 0 0  nanomolar 
Fig. 12. 
Extracellular 
recordings of a. a 
brisk sustained ON- 
center ganglion cell 
and b. An ON-OFF 
directionally 
selective ganglion 
cell in the rabbit 
retina before and 
during applications 
of SP in a perfusate 
over the retina. The 
major effect of SP is 
to increase the 
spontaneous 
activity of both cells. 
Their receptive field 
characteristics are 
unaltered. See text 
for further details. 
From Zalutsky and 
Miller (1 990). 
Substance P in the retina 
bipolar cells in goldfish retina are affected by SP to 
produce voltage-dependent inhibition of calcium 
currents (Ayoub and Matthews, 1992) so a secondary 
bipolar route for SP effects on ganglion cells is feasible. 
However, selective blocking of SP effects on rabbit 
ganglion cells by using SP analogs and receptor blockers 
has also been demonstrated (Zalutsky and Miller, 1990), 
thus indicating a direct synaptic route as well, at least for 
some varieties of ganglion cells. Thus, taking al1 the 
evidence conceming SPs occurrence in specific neurons 
with specific neurocircuitry together with the recent 
knowledge on SPs physiological action, leads to a 
conclusion that S P  is an important excitatory 
neurotransmitter in the vertebrate retina that deserves 
considerably more attention in future studies. 
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